Latest Market News

Microba Life Sciences has secured a $3.06 million R&D tax incentive refund for FY25, reinforcing its cash reserves and supporting ongoing advancements in gastrointestinal diagnostics and clinical therapeutics.

Phoslock Environmental Technologies is set to resume production at its Changxing factory after a four-year halt, signaling renewed confidence in market demand and operational stability.

QuickFee Limited has completed a $28.5 million capital return following the sale of its US Pay Now and Connect businesses, while updating its dividend policy to target regular shareholder cash distributions starting in FY26.

Transurban Group has announced a 34-cent unfranked dividend per stapled security for the six months ending December 2025, alongside a Dividend Reinvestment Plan with no discount.

Invion Limited has expanded its global rights to the Photosoft™ technology, gaining exclusive perpetual licenses across a broad range of human and animal diseases, including cancers and infectious diseases. This milestone-based deal positions Invion to accelerate clinical development and commercialisation worldwide.

Control Bionics Limited is set to acquire the remaining stake in Neuro Elite Athletics, integrating the NeuroBounce athletic performance program with its EMG technology to accelerate growth in key markets.

BetMakers Technology Group has secured a favorable three-year content distribution agreement with Penn Entertainment, alongside strong digital customer growth that signals robust momentum for FY26 and beyond.

Transurban Group has announced a 34.0 cents per stapled security interim distribution for the half-year ending December 2025, reaffirming its full-year FY26 guidance of 69.0 cents. The Distribution Reinvestment Plan will proceed without a discount, signaling steady confidence amid ongoing market conditions.

Optiscan Imaging Ltd has initiated Australia’s first intra-operative head and neck cancer imaging study using its advanced InVue® and InForm™ devices, aiming to enhance surgical precision and support FDA regulatory submissions.

BCAL Diagnostics has secured national ethics approval to establish a large-scale registry tracking the clinical impact of its BREASTESTplus blood test for breast cancer diagnosis, aiming to enhance doctor adoption and reimbursement prospects.

Iceni Gold has launched a targeted two-hole diamond drilling program at its Guyer prospect, aiming to extend promising high-grade gold mineralisation identified earlier this year. Results expected in December will shape exploration plans for 2026.

TechGen Metals reports impressive high-grade gold assays up to 39.3g/t from rock chip samples at its newly acquired Dalgaranga Gold Project in Western Australia, highlighting a promising exploration opportunity along a major regional shear zone.